- Home
- RVSB vs BIOA Comparison
RVSB vs BIOA Comparison
Compare RVSB & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSB
- BIOA
- Stock Information
- Founded
- RVSB 1923
- BIOA 2015
- Country
- RVSB United States
- BIOA United States
- Employees
- RVSB N/A
- BIOA N/A
- Industry
- RVSB Savings Institutions
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- RVSB Finance
- BIOA Health Care
- Exchange
- RVSB Nasdaq
- BIOA Nasdaq
- Market Cap
- RVSB 120.0M
- BIOA 139.1M
- IPO Year
- RVSB 1993
- BIOA 2024
- Fundamental
- Price
- RVSB $5.91
- BIOA $4.13
- Analyst Decision
- RVSB
- BIOA Hold
- Analyst Count
- RVSB 0
- BIOA 4
- Target Price
- RVSB N/A
- BIOA $5.67
- AVG Volume (30 Days)
- RVSB 67.4K
- BIOA 361.3K
- Earning Date
- RVSB 04-28-2025
- BIOA 05-15-2025
- Dividend Yield
- RVSB 1.36%
- BIOA N/A
- EPS Growth
- RVSB N/A
- BIOA N/A
- EPS
- RVSB 0.04
- BIOA N/A
- Revenue
- RVSB $46,646,000.00
- BIOA N/A
- Revenue This Year
- RVSB $4.26
- BIOA N/A
- Revenue Next Year
- RVSB $8.70
- BIOA N/A
- P/E Ratio
- RVSB $157.97
- BIOA N/A
- Revenue Growth
- RVSB N/A
- BIOA N/A
- 52 Week Low
- RVSB $3.30
- BIOA $2.88
- 52 Week High
- RVSB $6.38
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- RVSB 61.17
- BIOA N/A
- Support Level
- RVSB $5.68
- BIOA N/A
- Resistance Level
- RVSB $5.80
- BIOA N/A
- Average True Range (ATR)
- RVSB 0.18
- BIOA 0.00
- MACD
- RVSB -0.01
- BIOA 0.00
- Stochastic Oscillator
- RVSB 67.19
- BIOA 0.00
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.